Product Details
Evkeeza
Evinacumab345 mg/2.3 mL (150 mg/mL)
Concentrate for solution for infusion
2.3-mL Single-Use Vial
DIN/PIN/NPN
02541769
Manufacturer
Ultragenyx Pharmaceutical Inc.
Formulary Listing Date
2025-10-20
Unit Price
29.4600
Amount MOH Pays
29.4600
Coverage Status
Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
C10AX17
Interchangeable Products
NOLU Clinical Criteria
NORequirements
EAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – January 1, 2025 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |